CLINICAL_TRIALS
withdrawal
· 2015-07-27
Clinical Trial Update: Duodenal Exclusion for the Treatment of Type 2 Diabetes [NA]
Summary
Medtronic-sponsored trial of duodenal exclusion for Type 2 diabetes has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medtronic - MITG | Conditions: Diabetes | NA | Status: WITHDRAWN